We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Steven Filby, MD

Steven Filby, MD

  • Program Director, Interventional Cardiology, UH Cleveland Medical Center
  • Assistant Professor, CWRU School of Medicine
  • Specialty: Cardiology-Interventional Cardiology

Biography: Steven Filby, MD

Certifications & Memberships

  • Interventional Cardiology - American Board of Internal Medicine
  • Cardiovascular Disease - American Board of Internal Medicine


Fellowship | Advanced Interventional and Structural Cardiology
Advanced Interventional and Structural Cardiology - Cleveland Clinic (2008 - 2009)

Fellowship | Interventional Cardiology
Interventional Cardiology - Cleveland Clinic (2007 - 2008)

Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Of North Carolina Health Care (2004 - 2007)

Residency | Internal Medicine
Internal Medicine - Stanford Hospital And Clinics (2001 - 2004)

Medical Education
Louisiana State University School Of Medicine (1997 - 2001)

Harvard University (1995)


Steven Filby, MD, is an interventional cardiologist and director of the cardiac catheterization laboratory at University Hospitals Cleveland Medical Center.

Dr. Filby’s practice focuses on the medical and percutaneous treatment of coronary artery disease and structural heart disease. He has advanced training in the minimally invasive repair of congenital and valvular heart abnormalities. With more than 10 years experience, he previously practiced at FirstHealth of the Carolinas in Pinehurst, North Carolina, where he served as director of the transcatheter aortic valve replacement (TAVR) program and chief of cardiology.

Born and raised in New Orleans, Dr. Filby graduated from Harvard University with honors and obtained his medical degree from Louisiana State University School of Medicine in New Orleans. He completed his internal medicine residency at Stanford University Hospital and cardiology fellowship at University of North Carolina Health Care in Chapel Hill. Dr. Filby then completed a two year advanced fellowship in interventional cardiology, peripheral and structural intervention at the Cleveland Clinic. Dr. Filby is board-certified in cardiovascular medicine and interventional cardiology and board- eligible in vascular medicine.

Dr. Filby and his wife, Kimberly, have three daughters. He enjoys running, swimming and reading. Dr. Filby is also an avid beekeeper and a lifelong New Orleans Saints fan. He is a member of the Endymion Carnival Club and participates in the Mardi Gras parades each year.

Research & Publications

Research Links

View Research


Watch to find out more about this University Hospitals provider.

Click on the Playlist icon in the upper right-hand corner of the video to see all available videos from this provider.

Related Blog Articles

Watchman FLX product illustration

Innovation and Procedural Success with LAAC Advanced Imaging

Innovations in Cardiovascular Medicine & Surgery | Summer 2023

Same-Day Discharge Offers Excellent Outcomes, Patient Satisfaction for Percutaneous Cardiac Procedures

Innovations in Cardiovascular Medicine & Surgery | Summer 2022

UH Team First to Report Using Cardiac MRI for LAAC Pre-procedure Planning

Approach is a solution for the current contrast media shortage, as well as other scenarios - Innovations in Cardiovascular Medicine & Surgery | Summer 2022


Two Heart Procedures Recognized with Centers of Excellence Designation

Left atrial appendage occlusion and atrial fibrillation ablation offered at University Hospitals Harrington Heart & Vascular Institute receive national recognition - Innovations in Cardiovascular Medicine & Surgery | Fall 2021

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Van Warren did not disclose any Outside Relationships with Industry.